NL191150B - N-(L-leucyl) doxorubicine en zuur-additiezouten daarvan, werkwijze ter bereiding en farmaceutische preparaat. - Google Patents

N-(L-leucyl) doxorubicine en zuur-additiezouten daarvan, werkwijze ter bereiding en farmaceutische preparaat.

Info

Publication number
NL191150B
NL191150B NL7905953A NL7905953A NL191150B NL 191150 B NL191150 B NL 191150B NL 7905953 A NL7905953 A NL 7905953A NL 7905953 A NL7905953 A NL 7905953A NL 191150 B NL191150 B NL 191150B
Authority
NL
Netherlands
Prior art keywords
preparation
leucyl
doxorubicin
acid addition
addition salts
Prior art date
Application number
NL7905953A
Other languages
English (en)
Other versions
NL7905953A (nl
NL191150C (nl
Original Assignee
Ass A But Scienti Internationa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ass A But Scienti Internationa filed Critical Ass A But Scienti Internationa
Publication of NL7905953A publication Critical patent/NL7905953A/nl
Publication of NL191150B publication Critical patent/NL191150B/nl
Application granted granted Critical
Publication of NL191150C publication Critical patent/NL191150C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7905953A 1978-08-03 1979-08-02 N-(L-leucyl) doxorubicine en zuur-additiezouten daarvan, werkwijze ter bereiding en farmaceutische preparaat. NL191150C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE869485 1978-08-03
BE869485 1978-08-03

Publications (3)

Publication Number Publication Date
NL7905953A NL7905953A (nl) 1980-02-05
NL191150B true NL191150B (nl) 1994-09-16
NL191150C NL191150C (nl) 1995-02-16

Family

ID=3861689

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7905953A NL191150C (nl) 1978-08-03 1979-08-02 N-(L-leucyl) doxorubicine en zuur-additiezouten daarvan, werkwijze ter bereiding en farmaceutische preparaat.

Country Status (6)

Country Link
US (1) US4296105A (nl)
JP (1) JPS5522697A (nl)
CA (1) CA1115694A (nl)
FR (1) FR2432525A1 (nl)
GB (1) GB2027024B (nl)
NL (1) NL191150C (nl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977082A (en) * 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
JPH0541224Y2 (nl) * 1987-06-08 1993-10-19
US6143864A (en) * 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
US5866679A (en) * 1994-06-28 1999-02-02 Merck & Co., Inc. Peptides
US5599686A (en) * 1994-06-28 1997-02-04 Merck & Co., Inc. Peptides
BE1008581A3 (fr) * 1994-08-19 1996-06-04 Wallone Region Prodrogues, composition pharmaceutique les comprenant et leur utilisation.
NZ291368A (en) * 1994-08-19 1999-04-29 Wallone Region A compound comprising a marker or a therapeutic agent linked to a ligand containing amino acids wherein the marker or agent is cleaved from the ligand to permit entry into the cell of the marker or agent, medicaments for treating tumours; diagnostic devices
JP2543434Y2 (ja) * 1996-04-15 1997-08-06 マツダ株式会社 エンジンの排気管構造
US5998362A (en) * 1996-09-12 1999-12-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US5948750A (en) * 1996-10-30 1999-09-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6391305B1 (en) 1997-09-10 2002-05-21 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
BR9815116A (pt) * 1997-12-02 2000-10-10 Merck & Co Inc Conjugado, composição farmacêutica, e, processo para tratar câncer de próstata, e para tratar hiperplasia prostática benigna
US20040081659A1 (en) * 1997-12-02 2004-04-29 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
ZA9810974B (en) * 1997-12-02 1999-06-03 Merck & Co Inc Conjugates useful in the treatment of prostate cancer
US6174858B1 (en) 1998-11-17 2001-01-16 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US7425541B2 (en) 1998-12-11 2008-09-16 Medarex, Inc. Enzyme-cleavable prodrug compounds
CA2388700A1 (en) 1999-10-19 2001-04-26 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6355611B1 (en) 1999-10-27 2002-03-12 Merck & Co., Inc. Salt form of a conjugate useful in the treatment of prostate cancer
CA2388844A1 (en) * 1999-11-12 2001-05-25 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors
WO2001095943A2 (en) 2000-06-14 2001-12-20 Medarex, Inc. Prodrug compounds with an oligopeptide having an isoleucine residue
AU2001286727A1 (en) * 2000-08-24 2002-03-04 Coulter Pharmaceutical, Inc. Prodrugs activated by plasmin and their use in cancer chemotherapy
US20030232760A1 (en) * 2001-09-21 2003-12-18 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US20030216758A1 (en) * 2001-12-28 2003-11-20 Angiotech Pharmaceuticals, Inc. Coated surgical patches
PT1509256E (pt) * 2002-05-24 2009-10-15 Angiotech Int Ag Composições e métodos de revestimento de implantes médicos
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
CA2497349C (en) 2002-09-26 2008-07-08 Angiotech International Ag Perivascular wraps
JP2006516548A (ja) 2002-12-30 2006-07-06 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 迅速ゲル化ポリマー組成物からの薬物送達法
JP2007514472A (ja) * 2003-11-20 2007-06-07 アンジオテック インターナショナル アーゲー 軟組織移植片および瘢痕化抑制剤
WO2005072061A2 (en) * 2004-02-02 2005-08-11 Biosight Ltd. Conjugates for cancer therapy and diagnosis
AU2005100176A4 (en) * 2005-03-01 2005-04-07 Gym Tv Pty Ltd Garbage bin clip
WO2014160037A2 (en) 2013-03-14 2014-10-02 The Regents Of The University Of California Activatable membrane-interacting peptides and methods of use
EP3383407B1 (en) 2015-12-03 2023-12-06 BioSight Ltd. Cytarabine conjugates for cancer therapy
US11104698B2 (en) 2015-12-03 2021-08-31 Biosight Ltd. Salts of conjugates for cancer therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1578734A (nl) * 1967-11-28 1969-08-22
FR7164M (nl) * 1968-02-22 1969-08-04
FI51808C (fi) * 1968-07-15 1977-04-12 Rhone Poulenc Sa Menetelmä uusien kasvainten naftaseenijohdannaisten valmistamiseksi.
GB1500421A (en) * 1975-01-22 1978-02-08 Farmaceutici Italia Optically active anthracyclinones
US4012448A (en) * 1976-01-15 1977-03-15 Stanford Research Institute Synthesis of adriamycin and 7,9-epiadriamycin
FR2430425A1 (fr) * 1978-07-07 1980-02-01 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
US4296105A (en) 1981-10-20
JPS5522697A (en) 1980-02-18
FR2432525B1 (nl) 1983-12-02
GB2027024A (en) 1980-02-13
JPS6259715B2 (nl) 1987-12-12
NL7905953A (nl) 1980-02-05
NL191150C (nl) 1995-02-16
GB2027024B (en) 1983-04-27
FR2432525A1 (fr) 1980-02-29
CA1115694A (en) 1982-01-05

Similar Documents

Publication Publication Date Title
NL191150C (nl) N-(L-leucyl) doxorubicine en zuur-additiezouten daarvan, werkwijze ter bereiding en farmaceutische preparaat.
BE847742A (fr) Nouvelles imidazolidines, procede de preparation et compositions pharmaceutiques
NL190519B (nl) 4-gesubstitueerde fenylazijnzuurverbindingen, alsmede farmaceutische preparaten.
IT1194900B (it) N-(fenossialchile)immidazoli,relative composizioni farmaceutiche e procedimento per la loro fabbricazione
NL7610199A (nl) Werkwijze om naftochinoncarbonzuuresterderivaten te bereiden en om pesticidepreparaten te bereiden, welke deze bevatten.
ATE921T1 (de) Saeureadditionssalze von 2-beta, 16-beta-bis-piperidino-an drostan-16-beta-monoquaternaeren ammoniumderivaten und diese enthaltende pharmazeutische zusammensetzungen.
NO791205L (no) 2-(2-tenoyltio)-propionylglycin, fremgangsmaate for fremstilling derav og farmasoeytiske formuleringer som inneholder forbindelsen
IT7926362A0 (it) Composto 2-metil-diidropiridinico, procedimenti per la sua preparazione e composizione farmaceutica che lo comprende.
IT7927614A0 (it) 1,2,4,5-tetra-alchil-4-arilpiperidi ne e relative formulazioni farmaceutiche.
NL190662B (nl) Alfa-halogeenmethyl-alfa-aminozuurderivaten en farmaceutisch preparaat dat dit bevat.
NL188645C (nl) 1-azaxanthon-3-carbonzuurverbindingen en farmaceutische preparaten die deze verbindingen bevatten.
NL7901241A (nl) Nieuwe gesubstitueerde 2-fenylimino-imidazolidinen, de zuuradditiezouten daarvan, farmaceutische preparaten die deze bevatten, alsmede werkwijze voor de bereiding daarvan.
BE858356A (fr) Derives d'acide 7-acylamino-8-oxo-3-oxa-1-azabicyclo-(4.2.0)octane-2-carboxylique, leur procede de preparation et leur application en therapeutique
NL7903769A (nl) Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan.
NL174345C (nl) Zuur alkalicitraat, werkwijze ter bereiding daarvan en therapeutisch preparaat.
BE865816A (fr) Derives d'acide benzoique, leur procede de preparation et leur application therapeutique.
IT7926854A0 (it) Derivato di creatinolo o-fosfato ad azione terapeutica, procedimento per la sua preparazione e relativ-e composizioni farmaceutiche.
BE854850A (fr) Nouvelles imidazobenzoxazines et leurs sels, procede de preparation et compositions pharmaceutiques
IT7949534A0 (it) Midammidil)-cistammine e prodotto procedimento per la preparazione di ottenuto n,n-bis(n-ciano-n-alcinil)-metanim
IL58379A0 (en) N-(1-methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulphamoyl benzamide its oxide and salts their preparation and pharmaceutical compositions containing them
NL7502831A (nl) Werkwijze ter bereiding van n-(1'-allylpyrroli- dinyl 2'-methyl) 2-methoxy 4,5-azimidobenzamide, werkwijze ter bereiding van farmaceutische pre- paraten en gevormde preparaten.
NL177018C (nl) Fenylpropionzuurderivaten, alsmede dergelijke derivaten bevattende farmaceutische preparaten.
IL57218A (en) 9-deoxy-daunorubicin,9-deoxydoxorubicin,their acid addition salts,preparation thereof and pharmaceutical compositions comprising them
BE854046A (fr) Arylurees substituees, leur procede de preparation et compositions pharmaceutiques en contenant
NL7804229A (nl) Thienamycinederivaten, werkwijze ter bereiding daarvan, alsmede farmaceutische preparaten.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 19960301